Closed Viral Vector Manufacturing Platforms Global Market Report 2025
상품코드:1877567
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 17억 2,000만 달러에서 2025년에는 19억 6,000만 달러로 확대되고, CAGR 13.5%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 유전자 치료 조사 증가, 바이오의약품에 대한 투자 확대, 유전성 질환의 유병률 상승, 바이러스 벡터의 조기 도입, 헬스케어 지출의 확대 등이 요인으로 생각됩니다.
폐쇄형 바이러스 벡터 제조 플랫폼 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년까지 32억 1,000만 달러에 달하고, CAGR은 13.2%가 될 전망입니다. 예측 기간의 성장은 바이러스 벡터 수요 증가, 무균 및 확장 가능한 생산의 필요성, 유전자 치료에 대한 규제면의 지원, 세포 및 유전자 치료 파이프라인의 확대, 만성 질환의 유병률 상승에 기인한다고 생각됩니다. 예측기간의 주요 동향으로는 제조 공정에 자동화 도입, 일회용 바이오리액터의 채용, 프로세스 표준화의 중시, 바이오텍 기업과 CDMO 기업 간의 연계, 고수량 바이러스 생산 플랫폼의 개발 등을 들 수 있습니다.
임상시험 건수 증가는 폐쇄형 바이러스 벡터 제조 플랫폼 시장의 확대를 견인할 것으로 예측됩니다. 임상시험은 신규 의료요법이나 개입의 안전성, 효능, 적절한 사용법을 평가하기 위해 인간을 대상으로 신중하게 설계된 연구입니다. 만성 질환과 복잡한 질환의 유병률이 계속 증가하고 있는 가운데, 혁신적인 치료법에 대한 수요가 높아지고 있으며, 이는 임상시험 수요 증가를 뒷받침하고 있습니다. 폐쇄형 바이러스 벡터 제조 플랫폼은 바이러스 벡터의 일관된 멸균 생산을 제공하여 임상시험을 촉진하고 시험 중 치료법의 안전성과 신뢰성을 보장합니다. 예를 들어, 2024년 12월에 영국제약공업협회(ABPI)가 보고한 바에 따르면, 영국에서 시작된 업계 주도의 임상시험 총수는 2022년 411건에서 2023년 426건으로 증가하고 있으며, 이러한 플랫폼에 대한 수요 증가가 부각되고 있습니다.
본 시장의 기업은 세포 배양에서 질소에 의한 스트레스와 독성을 방지하는 니트로 컨트롤러 등의 첨단 솔루션 개발에도 주력하고 있습니다. 니트로 컨트롤러는 바이오프로세스 내의 질소 수준과 반응성 질소 종을 감시 및 조절하는 시스템으로 세포 증식과 제품 형성에 최적인 조건을 유지합니다. 2025년 5월에는 벨기에의 Univercells Technologies가 대규모 바이러스 벡터 및 백신 생산을 위해 설계된 컴팩트하고 비용 효율적인 시스템인 scale-X 니트로 컨트롤러를 발표했습니다. 200m2 및 600m2 scale-X 니트로 생물반응기와 호환되며 접착 세포 배양 및 부유 세포 배양을 모두 지원하여 AAV, 렌티바이러스 벡터, 엑소좀 및 종양 용해성 바이러스의 효율적인 생산을 가능하게 합니다. 또한 이 시스템은 R&D부터 상업 생산까지 8개월 이내의 신속한 스케일업을 실현합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 성장률 분석
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 실적 : 규모와 성장, 2019-2024년
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 제품 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
플라스미드 데옥시리보 핵산(DNA)
렌티바이러스 벡터
아데노바이러스 벡터
아데노 관련 바이러스 벡터
레트로바이러스 벡터
기타 제품 유형
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 워크플로우별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
업스트림 공정
다운스트림 공정
충전 및 마무리
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
유전자 치료
백신
세포치료
기타 용도
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제약 및 생명 공학 기업
학술연구기관
수탁제조기관
기타 최종 사용자
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 플라스미드 데옥시리보 핵산(DNA) 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
초나선 DNA
선형화 DNA
미니서클 DNA
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 렌티바이러스 벡터 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
통합형 렌티바이러스 벡터
비통합형 렌티바이러스 벡터
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 아데노바이러스 벡터 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
복제 결핍 아데노바이러스 벡터
복제 가능 아데노바이러스 벡터
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 아데노 관련 바이러스 벡터(AAV) 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
단일 가닥 AAV(ssAAV)
자기 상보성 AAV(scAAV)
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 레트로바이러스 벡터 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
감마 레트로 바이러스 벡터
알파 레트로 바이러스 벡터
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 기타 제품 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
단순 헤르페스 바이러스(HSV) 벡터
백시니아 바이러스 벡터
제7장 지역별/국가별 분석
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 경쟁 구도
폐쇄형 바이러스 벡터 제조 플랫폼 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Lonza Group AG : 개요, 제품 및 서비스, 전략 및 재무 분석
WuXi AppTec : 개요, 제품 및 서비스, 전략 및 재무 분석
Samsung Biologics Co. Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
FUJIFILM Biotechnologies
Oxford Biomedica Plc
Hillgene
Takara Bio Inc.
SkyPharma Production SAS
GeneScript ProBio
Obio Technology Corp. Ltd.
VectorBuilder
Charles River Laboratories Pvt. Ltd.
Creative Biogene
Esco Aster Pte. Ltd.
Karma Biotechnologies
Cell and Gene Therapy Catapult
CoJourney
Applied Biological Laboratories Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
폐쇄형 바이러스 벡터 제조 플랫폼 시장(2029년) : 새로운 기회를 제공하는 국가
폐쇄형 바이러스 벡터 제조 플랫폼 시장(2029년) : 새로운 기회를 제공하는 부문
폐쇄형 바이러스 벡터 제조 플랫폼 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Closed viral vector manufacturing platforms are fully enclosed systems designed to produce viral vectors in tightly controlled and sterile environments. They consolidate multiple production steps, including cell growth, vector assembly, purification, and formulation, within a sealed setup to minimize contamination and reduce human intervention. These platforms enhance process consistency, scalability, and regulatory compliance, ensuring high-quality vector production while maintaining safety and efficiency throughout the manufacturing cycle.
The main product types of closed viral vector manufacturing platforms include plasmid DNA, lentiviral vectors, adenoviral vectors, adeno-associated viral vectors, retroviral vectors, and others. Plasmid DNA consists of circular, double-stranded DNA molecules that act as essential templates for viral vector production or as direct gene delivery tools in non-viral gene therapy. Key workflows include upstream processing, downstream processing, and fill-finish, and they are applied for gene therapy, vaccines, cell therapy, and other applications. End users include pharmaceutical and biotechnology companies, academic and research institutes, contract manufacturing organizations, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The closed viral vector manufacturing platforms market research report is one of a series of new reports from The Business Research Company that provides closed viral vector manufacturing platforms market statistics, including closed viral vector manufacturing platforms industry global market size, regional shares, competitors with a closed viral vector manufacturing platforms market share, detailed closed viral vector manufacturing platforms market segments, market trends and opportunities, and any further data you may need to thrive in the closed viral vector manufacturing platforms industry. This closed viral vector manufacturing platforms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The closed viral vector manufacturing platforms market size has grown rapidly in recent years. It will grow from $1.72 billion in 2024 to $1.96 billion in 2025 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to increasing gene therapy research, rising investment in biopharmaceuticals, higher prevalence of genetic disorders, early adoption of viral vectors, and expanding healthcare expenditure.
The closed viral vector manufacturing platforms market size is expected to see rapid growth in the next few years. It will grow to $3.21 billion in 2029 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing demand for viral vectors, need for sterile and scalable production, regulatory support for gene therapies, expansion of cell and gene therapy pipelines, and rising prevalence of chronic diseases. Major trends in the forecast period include integration of automation in manufacturing, adoption of single-use bioreactors, emphasis on process standardization, collaboration between biotech and CDMO companies, and development of high-yield viral production platforms.
The growing number of clinical trials is expected to drive the expansion of the closed viral vector manufacturing platforms market. Clinical trials are carefully designed studies conducted in humans to evaluate the safety, efficacy, and proper use of new medical therapies or interventions. The increasing demand for clinical trials is fueled by the need for innovative treatments, as the prevalence of chronic and complex diseases continues to rise, creating a need for novel therapeutic solutions. Closed viral vector manufacturing platforms facilitate clinical trials by providing consistent, sterile production of viral vectors, ensuring the safety and reliability of the therapies being tested. For example, in December 2024, the Association of the British Pharmaceutical Industry (ABPI) reported that the total number of industry-sponsored clinical trials launched in the UK increased from 411 in 2022 to 426 in 2023, highlighting the growing demand for such platforms.
Companies in this market are also focusing on developing advanced solutions such as nitro controllers to prevent nitrogen-induced stress or toxicity in cell cultures. Nitro controllers are systems that monitor and regulate nitrogen levels or reactive nitrogen species in bioprocesses, maintaining optimal conditions for cell growth and product formation. In May 2025, Belgium-based Univercells Technologies launched the scale-X nitro controller, a compact and cost-efficient system designed for large-scale viral vector and vaccine production. Compatible with 200 m2 and 600 m2 scale-X nitro bioreactors, it supports both adherent and suspension cell cultures and enables efficient production of AAV, lentiviral vectors, exosomes, and oncolytic viruses. The system also allows rapid scale-up from research and development to commercial manufacturing within eight months.
In November 2023, Ajinomoto Co., Inc., a Japan-based biotechnology company, acquired Forge Biologics for $545 million. Through this acquisition, Ajinomoto gained Forge's 200,000-square-foot cGMP facility, the Hearth, in Columbus, Ohio, along with a workforce of over 300 employees. This expansion enhances Ajinomoto's global gene therapy manufacturing capabilities and strengthens its contract development and manufacturing services for AAV and plasmid-based therapies. Forge Biologics is a US-based company specializing in closed viral vector manufacturing platforms.
Major players in the closed viral vector manufacturing platforms market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, WuXi AppTec, Samsung Biologics Co. Ltd., FUJIFILM Biotechnologies, Oxford Biomedica Plc, Hillgene, Takara Bio Inc., SkyPharma Production SAS, GeneScript ProBio, Obio Technology Corp. Ltd., VectorBuilder, Charles River Laboratories Pvt. Ltd., Creative Biogene, Esco Aster Pte. Ltd., Karma Biotechnologies, Cell and Gene Therapy Catapult, CoJourney, Applied Biological Laboratories Inc., CEVEC Pharmaceuticals, and Genesail Biotech Co. Ltd.
North America was the largest region in the Closed Viral Vector Manufacturing Platforms market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in closed viral vector manufacturing platforms report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the closed viral vector manufacturing platforms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The closed viral vector manufacturing platforms market includes revenues earned by entities by providing services such as upstream process development, downstream process development, analytical development, and formulation development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Closed Viral Vector Manufacturing Platforms Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on closed viral vector manufacturing platforms market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for closed viral vector manufacturing platforms ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The closed viral vector manufacturing platforms market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Closed Viral Vector Manufacturing Platforms Market Trends And Strategies
4. Closed Viral Vector Manufacturing Platforms Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Closed Viral Vector Manufacturing Platforms Growth Analysis And Strategic Analysis Framework
5.1. Global Closed Viral Vector Manufacturing Platforms PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.1. Global Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Plasmid Deoxyribonucleic Acid (DNA)
Lentiviral Vectors
Adenoviral Vectors
Adeno-Associated Viral Vectors
Retroviral Vectors
Other Product Types
6.2. Global Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Upstream Processing
Downstream Processing
Fill-Finish
6.3. Global Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gene Therapy
Vaccines
Cell Therapy
Other Applications
6.4. Global Closed Viral Vector Manufacturing Platforms Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Academic And Research Institutes
Contract Manufacturing Organizations
Other End Users
6.5. Global Closed Viral Vector Manufacturing Platforms Market, Sub-Segmentation Of Plasmid Deoxyribonucleic Acid (DNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Supercoiled DNA
Linearized DNA
Minicircle DNA
6.6. Global Closed Viral Vector Manufacturing Platforms Market, Sub-Segmentation Of Lentiviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Integrating Lentiviral Vectors
Non-Integrating Lentiviral Vectors
6.7. Global Closed Viral Vector Manufacturing Platforms Market, Sub-Segmentation Of Adenoviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Replication-Deficient Adenoviral Vectors
Replication-Competent Adenoviral Vectors
6.8. Global Closed Viral Vector Manufacturing Platforms Market, Sub-Segmentation Of Adeno-Associated Viral Vectors (AAV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Stranded AAV (ssAAV)
Self-Complementary AAV (scAAV)
6.9. Global Closed Viral Vector Manufacturing Platforms Market, Sub-Segmentation Of Retroviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gamma-Retroviral Vectors
Alpha-Retroviral Vectors
6.10. Global Closed Viral Vector Manufacturing Platforms Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Herpes Simplex Virus (HSV) Vectors
Vaccinia Virus Vectors
7. Closed Viral Vector Manufacturing Platforms Market Regional And Country Analysis
7.1. Global Closed Viral Vector Manufacturing Platforms Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Closed Viral Vector Manufacturing Platforms Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Closed Viral Vector Manufacturing Platforms Market
9.1. China Closed Viral Vector Manufacturing Platforms Market Overview
9.2. China Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Closed Viral Vector Manufacturing Platforms Market
10.1. India Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Closed Viral Vector Manufacturing Platforms Market
11.1. Japan Closed Viral Vector Manufacturing Platforms Market Overview
11.2. Japan Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Closed Viral Vector Manufacturing Platforms Market
12.1. Australia Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Closed Viral Vector Manufacturing Platforms Market
13.1. Indonesia Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Closed Viral Vector Manufacturing Platforms Market
14.1. South Korea Closed Viral Vector Manufacturing Platforms Market Overview
14.2. South Korea Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Closed Viral Vector Manufacturing Platforms Market
15.1. Western Europe Closed Viral Vector Manufacturing Platforms Market Overview
15.2. Western Europe Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Closed Viral Vector Manufacturing Platforms Market
16.1. UK Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Closed Viral Vector Manufacturing Platforms Market
21.1. Eastern Europe Closed Viral Vector Manufacturing Platforms Market Overview
21.2. Eastern Europe Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Closed Viral Vector Manufacturing Platforms Market
22.1. Russia Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Closed Viral Vector Manufacturing Platforms Market
23.1. North America Closed Viral Vector Manufacturing Platforms Market Overview
23.2. North America Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Closed Viral Vector Manufacturing Platforms Market
24.1. USA Closed Viral Vector Manufacturing Platforms Market Overview
24.2. USA Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Closed Viral Vector Manufacturing Platforms Market
26.1. South America Closed Viral Vector Manufacturing Platforms Market Overview
26.2. South America Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Closed Viral Vector Manufacturing Platforms Market
27.1. Brazil Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Closed Viral Vector Manufacturing Platforms Market
28.1. Middle East Closed Viral Vector Manufacturing Platforms Market Overview
28.2. Middle East Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Closed Viral Vector Manufacturing Platforms Market
29.1. Africa Closed Viral Vector Manufacturing Platforms Market Overview
29.2. Africa Closed Viral Vector Manufacturing Platforms Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Closed Viral Vector Manufacturing Platforms Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Closed Viral Vector Manufacturing Platforms Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Closed Viral Vector Manufacturing Platforms Market Competitive Landscape And Company Profiles
